The Biological Fate of a Novel Anticancer Drug Candidate TNBG-5602: Metabolic Profile, Interaction with CYP450, and Pharmacokinetics in Rats
TNBG-5602, a novel anticancer drug candidate, may induce the expression of PPARγ, causing targeted lipotoxicity in cancer tissues. In this study, the in vivo metabolism in rats, in vitro metabolism in recombinant cytochromes, molecular docking for the CYP binding site, and pharmacokinetics in rats w...
Main Authors: | Rui Li, Sha Zhou, Zongjie Gan, Lijuan Wang, Yu Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/8/2594 |
Similar Items
-
Research into the Bioengineering of a Novel α-Conotoxin from the Milked Venom of <i>Conus obscurus</i>
by: Sean Wiere, et al.
Published: (2022-10-01) -
Evaluation of the Anticancer Potential of Crude, Irradiated <i>Cerastes cerastes</i> Snake Venom and Propolis Ethanolic Extract & Related Biological Alterations
by: Mostafa I. Abdelglil, et al.
Published: (2021-11-01) -
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their Combinations
by: Giulio Spinozzi, et al.
Published: (2022-06-01) -
Synthesis and Optimization of Mesoporous Silica Nanoparticles for Ruthenium Polypyridyl Drug Delivery
by: Siti Norain Harun, et al.
Published: (2021-01-01) -
Evaluation of Cx43 Gap Junction Inhibitors Using a Quantitative Structure-Activity Relationship Model
by: Ramona Matusevičiūtė, et al.
Published: (2023-07-01)